Your browser doesn't support javascript.
loading
Therapeutic effectiveness of anlotinib combined with etoposide in extensive-stage small-cell lung cancer: a single-arm, phase II trial.
Wu, Yuan; Zhou, Xuefeng; Zhao, Weiqing; Wang, Qiong; Han, Zhengxiang; Wang, Lifeng; Zhou, Wenjie; Zhou, Tong; Song, Haizhu; Chen, Yong; Yang, Kaihua; Shi, Lin; Pan, Banzhou; Guo, Renhong; Zhou, Guoren; Jiang, Feng; Feng, Jifeng; Shen, Bo.
Afiliação
  • Wu Y; Department of Medical Oncology, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, 210009, China.
  • Zhou X; Department of Oncology, Dongtai People's Hospital, Dongtai, 224200, China.
  • Zhao W; Department of Oncology, The Third Affiliated Hospital of Soochow University, Suzhou, 213003, China.
  • Wang Q; Department of Oncology, The Jiangyin Clinical College of Xuzhou Medical University, Jiangyin, 214400, China.
  • Han Z; Department of Oncology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, 221004, China.
  • Wang L; The Comprehensive Cancer Center of Nanjing Drum Tower Hospital, Nanjing Drum Tower Hospital, Nanjing, 210008, China.
  • Zhou W; Department of Oncology, The Third Affiliated Hospital of Soochow University, Suzhou, 213003, China.
  • Zhou T; Department of Medical Oncology, Changzhou Cancer Hospital, Changzhou, 213001, China.
  • Song H; Department of Medical Oncology, Jinling Hospital, Nanjing, 210016, China.
  • Chen Y; Department of Medical Oncology, Affiliated Hospital of Yangzhou University, Yangzhou, 225001, China.
  • Yang K; Department of Radiotherapy and Oncology, Affiliated Hospital of Jiangnan University, Wuxi, 214122, China.
  • Shi L; Department of Medical Oncology, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, 210009, China.
  • Pan B; Department of Medical Oncology, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, 210009, China.
  • Guo R; Department of Medical Oncology, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, 210009, China.
  • Zhou G; Department of Medical Oncology, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, 210009, China.
  • Jiang F; Department of Thoracic Surgery, The Affiliated Cancer Hospital of Nanjing Medical University & Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research, Nanjing, 210009, China.
  • Feng J; Department of Medical Oncology, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, 210009, China.
  • Shen B; Department of Medical Oncology, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, 210009, China. shenbo987@126.com.
Invest New Drugs ; 41(6): 825-833, 2023 Dec.
Article em En | MEDLINE | ID: mdl-37837490
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Estomatite / Carcinoma de Pequenas Células do Pulmão / Hipertensão / Neoplasias Pulmonares Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Estomatite / Carcinoma de Pequenas Células do Pulmão / Hipertensão / Neoplasias Pulmonares Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article